In the national news: Utah patients caught between national and state law shell games….

Echoing a state slogan of a few decades ago, “Visit the Different World of Utah,” this nationally featured article highlights the inherent contradictions in the current approach the state legislature has taken, and the obdurate, archaic wall of irrational national DEA/FDA/NIDA policies.

Excerpt: ” ‘No other U.S. state is taking the research-before-legislation route because they realize it is futile,’ said Jahan Marcu of Americans for Safe Access [ASA], a national medical cannabis advocacy group.

‘It’s never been shown to work in the past, so we are not confident that it’s going to serve the needs of patients now,’ he said of the process.

A recent report from the prestigious National Academies of Sciences recommended that the gaps in research be filled through a national research agenda.

Karen Wilcox, chair of the U. of Utah’s Pharmacology and Toxicology department, has spent about 18 months studying how CBD can affect seizures. The application process alone took six months.

‘It just takes a lot of time and effort to fill out all the paperwork,’ she said. ‘It’s a nightmare.’

Resident Doug Rice [of both the Utah Epilepsy Foundation and a member of TRUCE’s Board] said Utah’s approach means his daughter, who has a genetic condition, is missing out on the one drug that completely eliminates her frequent seizures.”

Please read the entire article!


In covering and analyzing all news of interest to patients and providers, our research arm has been following the state’s new Cannabinoid Research law from legislative hopper to early implementation, and could never find any rational case for how it would really help Utah’s patients who can benefit TODAY from all that is already known about MC nearly as much as it would delay getting a beneficial program going.

Nor, while all properly designed scientific research is welcome, do we see such a case now, when the effort at best will simply add a few data points to the over 20,000 existing studies.

Giving faint support to “doing the science” is not the same thing as following the massive weight of existing evidence when it amounts to mainly another delay tactic. We agree with the remarks of all the parties quoted in the article about the essentially scientifically wrong-headedness of both the state and current federal policies.

#MMJ #Research #HB130 #ASA #GetSerious #TRUCE    

See full article – Hurdles expected for Utah’s medical marijuana research law